Peri-procedural DKA risk with SGLT2 inhibitors

Clinicians have been reminded again of the risk of adverse metabolic outcomes in patients with diabetes whose SGLT2 inhibitors are not withheld in the 48 hours before surgery. An Australian case series of 23 patients, published in the British Journal of Anaesthesia, found 20 patients (87%) developed ketosis – 13 without acidosis (57%) and 7 ...

Already a member?

Login to keep reading.

© 2021 the limbic